[
    {
        "id": 11177,
        "drug_name": "EOHILIA (budesonide oral suspension)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "People 11 years and older with eosinophilic esophagitis (EoE)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-12",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/185069",
        "note": "FDA approved on February 12, 2024.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.3700",
        "company_change": -0.19999999999999996,
        "company_percent_change": -1.37,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ],
            [
                14.81,
                1708923600
            ],
            [
                14.84,
                1709010000
            ],
            [
                14.65,
                1709096400
            ],
            [
                14.59,
                1709182800
            ],
            [
                14.56,
                1709269200
            ],
            [
                14.48,
                1709528400
            ],
            [
                14.4,
                1709614800
            ],
            [
                14.69,
                1709701200
            ],
            [
                14.86,
                1709787600
            ],
            [
                14.77,
                1709874000
            ],
            [
                14.57,
                1710129600
            ],
            [
                14.37,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4054,
        "drug_name": "Onivyde (NALIRIFOX)",
        "clinical_trial_id": "NCT04083235",
        "has_trial_insight_page": 1,
        "indication": "Pancreatic cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-13",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/IPSEY\/news\/185470",
        "note": "FDA Approved on February 13, 2024.",
        "company_entity_id": 191,
        "company_ticker": "MACK",
        "company_name": "Merrimack Pharmaceuticals Inc.",
        "company_price": "14.6500",
        "company_change": -0.010000000000000009,
        "company_percent_change": -0.06999999999999995,
        "company_optionable": 1,
        "company_number_of_shares": 14516170,
        "price_change_sparkline": [
            [
                13.4,
                1706677200
            ],
            [
                13.3,
                1706763600
            ],
            [
                13.13,
                1706850000
            ],
            [
                13.36,
                1707109200
            ],
            [
                13.25,
                1707195600
            ],
            [
                13.06,
                1707282000
            ],
            [
                13.62,
                1707368400
            ],
            [
                13.8,
                1707454800
            ],
            [
                13.99,
                1707714000
            ],
            [
                15,
                1707800400
            ],
            [
                14.67,
                1707886800
            ],
            [
                14.7,
                1707973200
            ],
            [
                14.7,
                1708059600
            ],
            [
                14.7,
                1708405200
            ],
            [
                14.68,
                1708491600
            ],
            [
                14.72,
                1708578000
            ],
            [
                14.73,
                1708664400
            ],
            [
                14.7,
                1708923600
            ],
            [
                14.71,
                1709010000
            ],
            [
                14.7,
                1709096400
            ],
            [
                14.7,
                1709182800
            ],
            [
                14.74,
                1709269200
            ],
            [
                14.69,
                1709528400
            ],
            [
                14.69,
                1709614800
            ],
            [
                14.71,
                1709701200
            ],
            [
                14.77,
                1709787600
            ],
            [
                14.72,
                1709874000
            ],
            [
                14.66,
                1710129600
            ],
            [
                14.65,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 4054,
        "drug_name": "Onivyde (NALIRIFOX)",
        "clinical_trial_id": "NCT04083235",
        "has_trial_insight_page": 1,
        "indication": "Pancreatic cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-13",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/IPSEY\/news\/185470",
        "note": "FDA Approved on February 13, 2024.",
        "company_entity_id": 2251,
        "company_ticker": "IPSEY",
        "company_name": "Ipsen ADR",
        "company_price": "29.1600",
        "company_change": 0.03,
        "company_percent_change": 0.1,
        "company_optionable": 0,
        "company_number_of_shares": 328117684,
        "price_change_sparkline": [
            [
                29.095,
                1706677200
            ],
            [
                28.85,
                1706763600
            ],
            [
                28.85,
                1706850000
            ],
            [
                28,
                1707109200
            ],
            [
                28.28,
                1707195600
            ],
            [
                29.2,
                1707282000
            ],
            [
                28.495,
                1707368400
            ],
            [
                28.664,
                1707454800
            ],
            [
                28.664,
                1707714000
            ],
            [
                28.22,
                1707800400
            ],
            [
                27.82,
                1707886800
            ],
            [
                28.5,
                1707973200
            ],
            [
                28.405,
                1708059600
            ],
            [
                28.874,
                1708405200
            ],
            [
                28.0425,
                1708491600
            ],
            [
                28.295,
                1708578000
            ],
            [
                28.4675,
                1708664400
            ],
            [
                28.06,
                1708923600
            ],
            [
                28.185,
                1709010000
            ],
            [
                27.67,
                1709096400
            ],
            [
                27.86,
                1709182800
            ],
            [
                27.74,
                1709269200
            ],
            [
                27.78,
                1709528400
            ],
            [
                27.498,
                1709614800
            ],
            [
                27.69,
                1709701200
            ],
            [
                28.69,
                1709787600
            ],
            [
                28.31,
                1709874000
            ],
            [
                29.13,
                1710129600
            ],
            [
                29.16,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10554,
        "drug_name": "XOLAIR (omalizumab) - (OUtMATCH)",
        "clinical_trial_id": "NCT03881696",
        "has_trial_insight_page": 0,
        "indication": "Food allergy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RHHBY\/news\/186233",
        "note": "FDA Approved on February 16, 2024.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3619,
        "drug_name": "AMTAGVI (Lifileucel (LN-144)) - (TILVANCE-301)",
        "clinical_trial_id": "NCT02360579",
        "has_trial_insight_page": 0,
        "indication": "Refractory metastatic melanoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/IOVA\/news\/186274",
        "note": "FDA Approved on February 16, 2024.",
        "company_entity_id": 427,
        "company_ticker": "IOVA",
        "company_name": "Iovance Biotherapeutics Inc.",
        "company_price": "14.7200",
        "company_change": -0.38,
        "company_percent_change": -2.52,
        "company_optionable": 1,
        "company_number_of_shares": 279307043,
        "price_change_sparkline": [
            [
                7.73,
                1706677200
            ],
            [
                8.06,
                1706763600
            ],
            [
                7.9,
                1706850000
            ],
            [
                7.92,
                1707109200
            ],
            [
                8.16,
                1707195600
            ],
            [
                8.07,
                1707282000
            ],
            [
                8.68,
                1707368400
            ],
            [
                9.18,
                1707454800
            ],
            [
                9.95,
                1707714000
            ],
            [
                9.16,
                1707800400
            ],
            [
                9.55,
                1707886800
            ],
            [
                9.87,
                1707973200
            ],
            [
                9.15,
                1708059600
            ],
            [
                12.03,
                1708405200
            ],
            [
                15.77,
                1708491600
            ],
            [
                15.94,
                1708578000
            ],
            [
                15.77,
                1708664400
            ],
            [
                16.6,
                1708923600
            ],
            [
                17.47,
                1709010000
            ],
            [
                17.43,
                1709096400
            ],
            [
                15.91,
                1709182800
            ],
            [
                16.79,
                1709269200
            ],
            [
                16.96,
                1709528400
            ],
            [
                16.49,
                1709614800
            ],
            [
                17.16,
                1709701200
            ],
            [
                16.62,
                1709787600
            ],
            [
                15.7,
                1709874000
            ],
            [
                15.1,
                1710129600
            ],
            [
                14.72,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5234,
        "drug_name": "TAGRISSO (Osimertinib) - (FLAURA2)",
        "clinical_trial_id": "NCT02296125",
        "has_trial_insight_page": 1,
        "indication": "Non-small cell lung cancer (NSCLC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-17",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AZN\/news\/186326",
        "note": "Approved February 17, 2024.",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "67.4000",
        "company_change": -0.27,
        "company_percent_change": -0.4,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ],
            [
                65.93,
                1708923600
            ],
            [
                66.33,
                1709010000
            ],
            [
                65.35,
                1709096400
            ],
            [
                64.16,
                1709182800
            ],
            [
                64.6,
                1709269200
            ],
            [
                64.79,
                1709528400
            ],
            [
                64.81,
                1709614800
            ],
            [
                65.27,
                1709701200
            ],
            [
                66.19,
                1709787600
            ],
            [
                66.5,
                1709874000
            ],
            [
                67.67,
                1710129600
            ],
            [
                67.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9887,
        "drug_name": "TECVAYLI (teclistamab)",
        "clinical_trial_id": "NCT04557098",
        "has_trial_insight_page": 0,
        "indication": "Relapsed or refractory (R\/R) multiple myeloma.",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/JNJ\/news\/186789",
        "note": "Supplemental approval granted by the FDA, noted February 20, 2024.",
        "company_entity_id": 380,
        "company_ticker": "JNJ",
        "company_name": "Johnson & Johnson",
        "company_price": "162.7400",
        "company_change": 1.51,
        "company_percent_change": 0.94,
        "company_optionable": 1,
        "company_number_of_shares": 2408767228,
        "price_change_sparkline": [
            [
                157.701248890579,
                1706677200
            ],
            [
                157.165322682896,
                1706763600
            ],
            [
                155.428524787625,
                1706850000
            ],
            [
                154.6246354761,
                1707109200
            ],
            [
                156.867585900849,
                1707195600
            ],
            [
                156.788189425637,
                1707282000
            ],
            [
                155.220109040193,
                1707368400
            ],
            [
                155.577393178648,
                1707454800
            ],
            [
                156.659170153417,
                1707714000
            ],
            [
                155.289580956004,
                1707800400
            ],
            [
                154.565088119691,
                1707886800
            ],
            [
                156.728642069228,
                1707973200
            ],
            [
                156.55,
                1708059600
            ],
            [
                157.86,
                1708405200
            ],
            [
                158.68,
                1708491600
            ],
            [
                160.45,
                1708578000
            ],
            [
                161.84,
                1708664400
            ],
            [
                160.79,
                1708923600
            ],
            [
                160.98,
                1709010000
            ],
            [
                161.55,
                1709096400
            ],
            [
                161.38,
                1709182800
            ],
            [
                162.12,
                1709269200
            ],
            [
                159.84,
                1709528400
            ],
            [
                159.97,
                1709614800
            ],
            [
                159.34,
                1709701200
            ],
            [
                158.87,
                1709787600
            ],
            [
                159.52,
                1709874000
            ],
            [
                161.23,
                1710129600
            ],
            [
                162.74,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9628,
        "drug_name": "SIMLANDI (adalimumab-ryvk) - (Humira biosimilar)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Inflammatory diseases",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-23",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TEVA\/news\/187625",
        "note": "Approved February 23, 2024.",
        "company_entity_id": 390,
        "company_ticker": "TEVA",
        "company_name": "Teva Pharmaceutical Industries Limited American Depositary Shares",
        "company_price": "13.4900",
        "company_change": 0.14,
        "company_percent_change": 1.05,
        "company_optionable": 1,
        "company_number_of_shares": 1121094011,
        "price_change_sparkline": [
            [
                12.1,
                1706677200
            ],
            [
                12.46,
                1706763600
            ],
            [
                12.28,
                1706850000
            ],
            [
                12.38,
                1707109200
            ],
            [
                12.25,
                1707195600
            ],
            [
                12.14,
                1707282000
            ],
            [
                12.09,
                1707368400
            ],
            [
                12.01,
                1707454800
            ],
            [
                12.91,
                1707714000
            ],
            [
                12.92,
                1707800400
            ],
            [
                13.17,
                1707886800
            ],
            [
                13.2,
                1707973200
            ],
            [
                13.02,
                1708059600
            ],
            [
                13.07,
                1708405200
            ],
            [
                13,
                1708491600
            ],
            [
                13.05,
                1708578000
            ],
            [
                12.89,
                1708664400
            ],
            [
                13.29,
                1708923600
            ],
            [
                13.3,
                1709010000
            ],
            [
                13.09,
                1709096400
            ],
            [
                13.15,
                1709182800
            ],
            [
                13.5,
                1709269200
            ],
            [
                13.44,
                1709528400
            ],
            [
                13.54,
                1709614800
            ],
            [
                13.53,
                1709701200
            ],
            [
                13.71,
                1709787600
            ],
            [
                13.62,
                1709874000
            ],
            [
                13.35,
                1710129600
            ],
            [
                13.49,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9628,
        "drug_name": "SIMLANDI (adalimumab-ryvk) - (Humira biosimilar)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Inflammatory diseases",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-23",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TEVA\/news\/187625",
        "note": "Approved February 23, 2024.",
        "company_entity_id": 1505,
        "company_ticker": "ALVO",
        "company_name": "Alvotech",
        "company_price": "15.3200",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.71,
        "company_optionable": 0,
        "company_number_of_shares": 263510000,
        "price_change_sparkline": [
            [
                15.75,
                1706677200
            ],
            [
                15.95,
                1706763600
            ],
            [
                15.7,
                1706850000
            ],
            [
                15.49,
                1707109200
            ],
            [
                15.48,
                1707195600
            ],
            [
                15.61,
                1707282000
            ],
            [
                15.49,
                1707368400
            ],
            [
                15.66,
                1707454800
            ],
            [
                15.71,
                1707714000
            ],
            [
                15.66,
                1707800400
            ],
            [
                15.7,
                1707886800
            ],
            [
                15.8,
                1707973200
            ],
            [
                15.82,
                1708059600
            ],
            [
                15.97,
                1708405200
            ],
            [
                15.75,
                1708491600
            ],
            [
                15.57,
                1708578000
            ],
            [
                16.03,
                1708664400
            ],
            [
                17.27,
                1708923600
            ],
            [
                16.29,
                1709010000
            ],
            [
                15.9,
                1709096400
            ],
            [
                15.39,
                1709182800
            ],
            [
                15.76,
                1709269200
            ],
            [
                16,
                1709528400
            ],
            [
                16.16,
                1709614800
            ],
            [
                15.98,
                1709701200
            ],
            [
                16.02,
                1709787600
            ],
            [
                15.6,
                1709874000
            ],
            [
                15.43,
                1710129600
            ],
            [
                15.32,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9230,
        "drug_name": "BRUKINSA (zanubrutinib) + Obinutuzumab - (ROSEWOOD)",
        "clinical_trial_id": "NCT03332017",
        "has_trial_insight_page": 0,
        "indication": "Follicular Non-Hodgkin Lymphoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BGNE\/news\/187723",
        "note": "Approval noted February 26, 2024.",
        "company_entity_id": 340,
        "company_ticker": "BGNE",
        "company_name": "BeiGene Ltd.",
        "company_price": "163.7500",
        "company_change": -0.78,
        "company_percent_change": -0.47,
        "company_optionable": 1,
        "company_number_of_shares": 104577940,
        "price_change_sparkline": [
            [
                148.23,
                1706677200
            ],
            [
                149.93,
                1706763600
            ],
            [
                144.48,
                1706850000
            ],
            [
                141.81,
                1707109200
            ],
            [
                153.58,
                1707195600
            ],
            [
                147.76,
                1707282000
            ],
            [
                142.88,
                1707368400
            ],
            [
                146.98,
                1707454800
            ],
            [
                146.57,
                1707714000
            ],
            [
                141.8,
                1707800400
            ],
            [
                145.87,
                1707886800
            ],
            [
                146.07,
                1707973200
            ],
            [
                148.23,
                1708059600
            ],
            [
                148.05,
                1708405200
            ],
            [
                150.8,
                1708491600
            ],
            [
                153.78,
                1708578000
            ],
            [
                155.1,
                1708664400
            ],
            [
                160.26,
                1708923600
            ],
            [
                179.69,
                1709010000
            ],
            [
                178.48,
                1709096400
            ],
            [
                165.65,
                1709182800
            ],
            [
                165.02,
                1709269200
            ],
            [
                167.86,
                1709528400
            ],
            [
                160.42,
                1709614800
            ],
            [
                159.52,
                1709701200
            ],
            [
                162.25,
                1709787600
            ],
            [
                158.52,
                1709874000
            ],
            [
                164.53,
                1710129600
            ],
            [
                163.75,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2902,
        "drug_name": "Biktarvy",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "HIV",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-02-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GILD\/news\/187944",
        "note": "Approved for expanded indication to treat people with HIV (PWH) who have suppressed viral loads with known or suspected M184V\/I resistance, noted February 26, 2024.",
        "company_entity_id": 378,
        "company_ticker": "GILD",
        "company_name": "Gilead Sciences Inc.",
        "company_price": "75.0800",
        "company_change": -0.24,
        "company_percent_change": -0.31999999999999995,
        "company_optionable": 1,
        "company_number_of_shares": 1245774616,
        "price_change_sparkline": [
            [
                78.26,
                1706677200
            ],
            [
                78.16,
                1706763600
            ],
            [
                76.96,
                1706850000
            ],
            [
                76.71,
                1707109200
            ],
            [
                77.72,
                1707195600
            ],
            [
                74.42,
                1707282000
            ],
            [
                73.8,
                1707368400
            ],
            [
                73.67,
                1707454800
            ],
            [
                74.45,
                1707714000
            ],
            [
                73.53,
                1707800400
            ],
            [
                73.04,
                1707886800
            ],
            [
                73.37,
                1707973200
            ],
            [
                71.58,
                1708059600
            ],
            [
                72.04,
                1708405200
            ],
            [
                73.2,
                1708491600
            ],
            [
                72.78,
                1708578000
            ],
            [
                73.55,
                1708664400
            ],
            [
                72.95,
                1708923600
            ],
            [
                73.02,
                1709010000
            ],
            [
                72.7,
                1709096400
            ],
            [
                72.1,
                1709182800
            ],
            [
                72.31,
                1709269200
            ],
            [
                72.25,
                1709528400
            ],
            [
                72.99,
                1709614800
            ],
            [
                72.63,
                1709701200
            ],
            [
                73.66,
                1709787600
            ],
            [
                75.12,
                1709874000
            ],
            [
                75.32,
                1710129600
            ],
            [
                75.08,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10953,
        "drug_name": "Trogarzo (ibalizumab-uiyk)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "HIV",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2024-02-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/THTX\/news\/188124",
        "note": "IM method sBLA received a RTF letter, noted February 27, 2024.",
        "company_entity_id": 2306,
        "company_ticker": "THTX",
        "company_name": "Theratechnologies Inc.",
        "company_price": "1.2000",
        "company_change": -0.020000000000000018,
        "company_percent_change": -1.6400000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 45980019,
        "price_change_sparkline": [
            [
                1.55,
                1706677200
            ],
            [
                1.66,
                1706763600
            ],
            [
                1.67,
                1706850000
            ],
            [
                1.57,
                1707109200
            ],
            [
                1.65,
                1707195600
            ],
            [
                1.65,
                1707282000
            ],
            [
                1.57,
                1707368400
            ],
            [
                1.6254,
                1707454800
            ],
            [
                1.6773,
                1707714000
            ],
            [
                1.59,
                1707800400
            ],
            [
                1.62,
                1707886800
            ],
            [
                1.63,
                1707973200
            ],
            [
                1.65,
                1708059600
            ],
            [
                1.68,
                1708405200
            ],
            [
                1.7,
                1708491600
            ],
            [
                1.61,
                1708578000
            ],
            [
                1.635,
                1708664400
            ],
            [
                1.64,
                1708923600
            ],
            [
                1.6,
                1709010000
            ],
            [
                1.44,
                1709096400
            ],
            [
                1.45,
                1709182800
            ],
            [
                1.47,
                1709269200
            ],
            [
                1.52,
                1709528400
            ],
            [
                1.44,
                1709614800
            ],
            [
                1.37,
                1709701200
            ],
            [
                1.26,
                1709787600
            ],
            [
                1.21,
                1709874000
            ],
            [
                1.22,
                1710129600
            ],
            [
                1.2,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10140,
        "drug_name": "RYBREVANT (amivantamab) - (PAPILLON)",
        "clinical_trial_id": "NCT04538664",
        "has_trial_insight_page": 0,
        "indication": "Non-small cell lung cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-03-01",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/JNJ\/news\/189268",
        "note": "FDA approved on March 1, 2024.",
        "company_entity_id": 380,
        "company_ticker": "JNJ",
        "company_name": "Johnson & Johnson",
        "company_price": "162.7400",
        "company_change": 1.51,
        "company_percent_change": 0.94,
        "company_optionable": 1,
        "company_number_of_shares": 2408767228,
        "price_change_sparkline": [
            [
                157.701248890579,
                1706677200
            ],
            [
                157.165322682896,
                1706763600
            ],
            [
                155.428524787625,
                1706850000
            ],
            [
                154.6246354761,
                1707109200
            ],
            [
                156.867585900849,
                1707195600
            ],
            [
                156.788189425637,
                1707282000
            ],
            [
                155.220109040193,
                1707368400
            ],
            [
                155.577393178648,
                1707454800
            ],
            [
                156.659170153417,
                1707714000
            ],
            [
                155.289580956004,
                1707800400
            ],
            [
                154.565088119691,
                1707886800
            ],
            [
                156.728642069228,
                1707973200
            ],
            [
                156.55,
                1708059600
            ],
            [
                157.86,
                1708405200
            ],
            [
                158.68,
                1708491600
            ],
            [
                160.45,
                1708578000
            ],
            [
                161.84,
                1708664400
            ],
            [
                160.79,
                1708923600
            ],
            [
                160.98,
                1709010000
            ],
            [
                161.55,
                1709096400
            ],
            [
                161.38,
                1709182800
            ],
            [
                162.12,
                1709269200
            ],
            [
                159.84,
                1709528400
            ],
            [
                159.97,
                1709614800
            ],
            [
                159.34,
                1709701200
            ],
            [
                158.87,
                1709787600
            ],
            [
                159.52,
                1709874000
            ],
            [
                161.23,
                1710129600
            ],
            [
                162.74,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 11239,
        "drug_name": "DEFINITY (Perflutren Lipid Microsphere)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-03-04",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LNTH\/news\/189531",
        "note": "FDA approved on March 4, 2024.",
        "company_entity_id": 187,
        "company_ticker": "LNTH",
        "company_name": "Lantheus Holdings Inc.",
        "company_price": "60.8800",
        "company_change": -1.84,
        "company_percent_change": -2.93,
        "company_optionable": 1,
        "company_number_of_shares": 68525556,
        "price_change_sparkline": [
            [
                51.93,
                1706677200
            ],
            [
                53.01,
                1706763600
            ],
            [
                54,
                1706850000
            ],
            [
                54.06,
                1707109200
            ],
            [
                54.99,
                1707195600
            ],
            [
                54.6,
                1707282000
            ],
            [
                55.56,
                1707368400
            ],
            [
                56.14,
                1707454800
            ],
            [
                56.55,
                1707714000
            ],
            [
                54.89,
                1707800400
            ],
            [
                56.37,
                1707886800
            ],
            [
                57.75,
                1707973200
            ],
            [
                57.46,
                1708059600
            ],
            [
                56.83,
                1708405200
            ],
            [
                56.71,
                1708491600
            ],
            [
                65.05,
                1708578000
            ],
            [
                66.27,
                1708664400
            ],
            [
                68.14,
                1708923600
            ],
            [
                68.26,
                1709010000
            ],
            [
                65.37,
                1709096400
            ],
            [
                65.38,
                1709182800
            ],
            [
                64.64,
                1709269200
            ],
            [
                65.36,
                1709528400
            ],
            [
                64.44,
                1709614800
            ],
            [
                61.97,
                1709701200
            ],
            [
                62.59,
                1709787600
            ],
            [
                62.52,
                1709874000
            ],
            [
                62.72,
                1710129600
            ],
            [
                60.88,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10616,
        "drug_name": "Clobetasol propionate ophthalmic suspension 0.05% (APP13007)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Inflammation and pain associated with ocular surgery",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-03-04",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/EYEN\/news\/189716",
        "note": "Approved March 4, 2024.",
        "company_entity_id": 531,
        "company_ticker": "EYEN",
        "company_name": "Eyenovia Inc.",
        "company_price": "1.6500",
        "company_change": 0.07,
        "company_percent_change": 4.43,
        "company_optionable": 1,
        "company_number_of_shares": 44122225,
        "price_change_sparkline": [
            [
                1.82,
                1706677200
            ],
            [
                1.9,
                1706763600
            ],
            [
                1.81,
                1706850000
            ],
            [
                1.75,
                1707109200
            ],
            [
                1.79,
                1707195600
            ],
            [
                1.765,
                1707282000
            ],
            [
                1.775,
                1707368400
            ],
            [
                1.83,
                1707454800
            ],
            [
                1.91,
                1707714000
            ],
            [
                1.8,
                1707800400
            ],
            [
                1.78,
                1707886800
            ],
            [
                1.76,
                1707973200
            ],
            [
                1.7,
                1708059600
            ],
            [
                1.605,
                1708405200
            ],
            [
                1.59,
                1708491600
            ],
            [
                1.67,
                1708578000
            ],
            [
                1.69,
                1708664400
            ],
            [
                1.98,
                1708923600
            ],
            [
                2.16,
                1709010000
            ],
            [
                2.3,
                1709096400
            ],
            [
                2.165,
                1709182800
            ],
            [
                2.37,
                1709269200
            ],
            [
                2.28,
                1709528400
            ],
            [
                1.76,
                1709614800
            ],
            [
                1.695,
                1709701200
            ],
            [
                1.72,
                1709787600
            ],
            [
                1.58,
                1709874000
            ],
            [
                1.58,
                1710129600
            ],
            [
                1.65,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 11270,
        "drug_name": "Wyost (denosumab-bddz) and Jubbonti (denosumab-bddz) interchangeable",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "multiple myeloma and in patients with bone metastases from solid tumors",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-03-05",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/9a393574-478c-4342-abe8-efc1b96960f4",
        "note": "FDA biosimilar of Xgeva (denosumab) and Prolia (denosumab) approved on March 5, 2024.",
        "company_entity_id": 386,
        "company_ticker": "NVS",
        "company_name": "Novartis AG",
        "company_price": "99.7700",
        "company_change": -1.6,
        "company_percent_change": -1.58,
        "company_optionable": 1,
        "company_number_of_shares": 2044033986,
        "price_change_sparkline": [
            [
                99.701426650332,
                1706677200
            ],
            [
                101.493681927897,
                1706763600
            ],
            [
                99.9423211768864,
                1706850000
            ],
            [
                99.701426650332,
                1707109200
            ],
            [
                99.9615927390107,
                1707195600
            ],
            [
                99.6917908692698,
                1707282000
            ],
            [
                97.6682768462129,
                1707368400
            ],
            [
                97.3502960711611,
                1707454800
            ],
            [
                96.8685070180523,
                1707714000
            ],
            [
                95.4520472019125,
                1707800400
            ],
            [
                95.4424114208503,
                1707886800
            ],
            [
                96.0012867224565,
                1707973200
            ],
            [
                96.5408904619384,
                1708059600
            ],
            [
                98.9787430706688,
                1708405200
            ],
            [
                98.824570573674,
                1708491600
            ],
            [
                99.0558293191662,
                1708578000
            ],
            [
                100.115765236006,
                1708664400
            ],
            [
                99.4894394669641,
                1708923600
            ],
            [
                99.3930816563424,
                1709010000
            ],
            [
                98.49695401756,
                1709096400
            ],
            [
                97.2924813847881,
                1709182800
            ],
            [
                98.3427815205652,
                1709269200
            ],
            [
                98.2560594910056,
                1709528400
            ],
            [
                98.3813246448139,
                1709614800
            ],
            [
                98.9016568221714,
                1709701200
            ],
            [
                99.93,
                1709787600
            ],
            [
                100.71,
                1709874000
            ],
            [
                101.37,
                1710129600
            ],
            [
                99.77,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9381,
        "drug_name": "Opdivo (nivolumab) plus Yervoy (ipilimumab)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Urothelial carcinoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-03-07",
        "link": "http:\/\/r.notification.biopharmcatalyst.com\/tr\/cl\/fXl69gBAFhZ7DEVVuLbPM0VQVdtqKCcFVuhWUbYw8vN2gMCankX-MBtzEwcdywuX3Ydl3yo6wam-ABPeSSrerdLs9jMolEYX9X8YUFNbt9CZMucSviD6oOWybWm3SYQQoEWlfHsC_xSwQV8af-APILR0CxAsIxU0Db1Pj9St2qzed0Bfb02kMGQQYG708Ke0MJrkC9VxEpzIgwSl7xHOX_uveKkQds6bo1YFeQYFsfgSg-hH-b0AYJY9DgBzEojv8xJid-VefRKogJIbH9I7UuyvrLwSnDfkWwsZlVa-qKEM3HlvewgoeAacIRvONoJ3l-S4gy7OX5pAG-X7jUSKLw",
        "note": "Approved March 7, 2024.",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10597,
        "drug_name": "Wegovy (Semaglutide)",
        "clinical_trial_id": "NCT03574597",
        "has_trial_insight_page": 0,
        "indication": "Cardiovascular risk reduction in adults with obesity",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-03-08",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/NVO\/news\/190880",
        "note": "Approved March 8, 2024.",
        "company_entity_id": 385,
        "company_ticker": "NVO",
        "company_name": "Novo Nordisk A\/S",
        "company_price": "135.1100",
        "company_change": 3.87,
        "company_percent_change": 2.95,
        "company_optionable": 1,
        "company_number_of_shares": 4510000000,
        "price_change_sparkline": [
            [
                114.74,
                1706677200
            ],
            [
                115.79,
                1706763600
            ],
            [
                113.7,
                1706850000
            ],
            [
                118.26,
                1707109200
            ],
            [
                117.61,
                1707195600
            ],
            [
                118.66,
                1707282000
            ],
            [
                118.39,
                1707368400
            ],
            [
                121.2,
                1707454800
            ],
            [
                120.53,
                1707714000
            ],
            [
                119.99,
                1707800400
            ],
            [
                123.29,
                1707886800
            ],
            [
                121.75,
                1707973200
            ],
            [
                124.01,
                1708059600
            ],
            [
                121.45,
                1708405200
            ],
            [
                120.93,
                1708491600
            ],
            [
                124.52,
                1708578000
            ],
            [
                123.45,
                1708664400
            ],
            [
                123.49,
                1708923600
            ],
            [
                122.23,
                1709010000
            ],
            [
                121.54,
                1709096400
            ],
            [
                119.77,
                1709182800
            ],
            [
                124.23,
                1709269200
            ],
            [
                127.95,
                1709528400
            ],
            [
                124.65,
                1709614800
            ],
            [
                124.75,
                1709701200
            ],
            [
                135.92,
                1709787600
            ],
            [
                133.07,
                1709874000
            ],
            [
                131.24,
                1710129600
            ],
            [
                135.11,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3284,
        "drug_name": "Sotagliflozin",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Type 1 Diabetes",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2024-03-11",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LXRX\/news\/191002",
        "note": "After public Notice of Opportunity for Hearing (NOOH) proceeding in late 2023, the FDA  issued feedback for sotagliflozin resbmisssion, noted March 11, 2024.",
        "company_entity_id": 190,
        "company_ticker": "LXRX",
        "company_name": "Lexicon Pharmaceuticals Inc.",
        "company_price": "2.5200",
        "company_change": -0.29000000000000004,
        "company_percent_change": -10.32,
        "company_optionable": 1,
        "company_number_of_shares": 244924695,
        "price_change_sparkline": [
            [
                1.87,
                1706677200
            ],
            [
                1.98,
                1706763600
            ],
            [
                2.13,
                1706850000
            ],
            [
                2.05,
                1707109200
            ],
            [
                2.21,
                1707195600
            ],
            [
                2.15,
                1707282000
            ],
            [
                2.3,
                1707368400
            ],
            [
                2.39,
                1707454800
            ],
            [
                2.92,
                1707714000
            ],
            [
                2.93,
                1707800400
            ],
            [
                3.32,
                1707886800
            ],
            [
                3.58,
                1707973200
            ],
            [
                3.18,
                1708059600
            ],
            [
                2.65,
                1708405200
            ],
            [
                2.51,
                1708491600
            ],
            [
                2.37,
                1708578000
            ],
            [
                2.54,
                1708664400
            ],
            [
                2.44,
                1708923600
            ],
            [
                2.62,
                1709010000
            ],
            [
                2.61,
                1709096400
            ],
            [
                2.49,
                1709182800
            ],
            [
                2.48,
                1709269200
            ],
            [
                2.21,
                1709528400
            ],
            [
                2.25,
                1709614800
            ],
            [
                2.19,
                1709701200
            ],
            [
                2.15,
                1709787600
            ],
            [
                2.17,
                1709874000
            ],
            [
                2.81,
                1710129600
            ],
            [
                2.52,
                1710216000
            ]
        ],
        "statuses": []
    }
]